APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Peptide Synthesis CDMO Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Peptide Synthesis CDMO Services Market Analysis and Forecast 2026-2032

Report ID 17421184023 May 2026249 pages

Choose your research edition.

Industry ResearchPeptide Synthesis CDMO Services Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Synthesis CDMO Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Peptide Synthesis CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Synthesis CDMO Services Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Synthesis CDMO Services Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Peptide Synthesis CDMO Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Peptide Synthesis CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Peptide Synthesis CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Peptide Synthesis CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Peptide Synthesis CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Peptide Synthesis CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Peptide Synthesis CDMO Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Peptide Synthesis CDMO Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Peptide Synthesis CDMO Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide Synthesis CDMO Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Peptide Synthesis CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Peptide Synthesis CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Peptide Synthesis CDMO Services Segment by Company

Bachem

CordenPharma

PolyPeptide

AmbioPharm

Genscript

Thermo Fisher

USV Peptides

Bio Basic

ScinoPharm

JPT

CBL

Piramal Pharma

CPC Scientific

Creative Peptides

Chinese Peptide Company

ChengDu ShengNuo Biotec

AppTec Co., Ltd.

GL Biochem

Peptide Synthesis CDMO Services Segment by Type

GMP Services

Non-GMP Services

Peptide Synthesis CDMO Services Segment by Application

Commercial

Scientific Research

Other

Peptide Synthesis CDMO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis CDMO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Peptide Synthesis CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Peptide Synthesis CDMO Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Synthesis CDMO Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. GMP Services Major Player Table 3. Non-GMP Services Major Player Table 4. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Commercial Major Player Table 6. Scientific Research Major Player Table 7. Other Major Player Table 8. Peptide Synthesis CDMO Services Industry Trends Table 9. Peptide Synthesis CDMO Services Industry Drivers Table 10. Peptide Synthesis CDMO Services Industry Opportunities and Challenges Table 11. Peptide Synthesis CDMO Services Industry Restraints Table 12. Global Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Peptide Synthesis CDMO Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Peptide Synthesis CDMO Services Market Share by Region (2021-2026) Table 15. Global Peptide Synthesis CDMO Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Peptide Synthesis CDMO Services Market Share by Region (2027-2032) Table 17. Global Peptide Synthesis CDMO Services Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Peptide Synthesis CDMO Services Revenue Market Share by Players (2021-2026) Table 19. Global Peptide Synthesis CDMO Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Peptide Synthesis CDMO Services Key Players Headquarters & Area Served Table 21. Global Peptide Synthesis CDMO Services Players, Product Type & Application Table 22. Global Peptide Synthesis CDMO Services Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Peptide Synthesis CDMO Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Peptide Synthesis CDMO Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Peptide Synthesis CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Peptide Synthesis CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2021-2026) Table 29. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2027-2032) Table 30. Global Peptide Synthesis CDMO Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Peptide Synthesis CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Peptide Synthesis CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021-2026) Table 34. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2027-2032) Table 35. Bachem Company Information Table 36. Bachem Business Overview Table 37. Bachem Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bachem Peptide Synthesis CDMO Services Product Portfolio Table 39. Bachem Recent Development Table 40. CordenPharma Company Information Table 41. CordenPharma Business Overview Table 42. CordenPharma Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CordenPharma Peptide Synthesis CDMO Services Product Portfolio Table 44. CordenPharma Recent Development Table 45. PolyPeptide Company Information Table 46. PolyPeptide Business Overview Table 47. PolyPeptide Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. PolyPeptide Peptide Synthesis CDMO Services Product Portfolio Table 49. PolyPeptide Recent Development Table 50. AmbioPharm Company Information Table 51. AmbioPharm Business Overview Table 52. AmbioPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AmbioPharm Peptide Synthesis CDMO Services Product Portfolio Table 54. AmbioPharm Recent Development Table 55. Genscript Company Information Table 56. Genscript Business Overview Table 57. Genscript Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genscript Peptide Synthesis CDMO Services Product Portfolio Table 59. Genscript Recent Development Table 60. Thermo Fisher Company Information Table 61. Thermo Fisher Business Overview Table 62. Thermo Fisher Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio Table 64. Thermo Fisher Recent Development Table 65. USV Peptides Company Information Table 66. USV Peptides Business Overview Table 67. USV Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. USV Peptides Peptide Synthesis CDMO Services Product Portfolio Table 69. USV Peptides Recent Development Table 70. Bio Basic Company Information Table 71. Bio Basic Business Overview Table 72. Bio Basic Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bio Basic Peptide Synthesis CDMO Services Product Portfolio Table 74. Bio Basic Recent Development Table 75. ScinoPharm Company Information Table 76. ScinoPharm Business Overview Table 77. ScinoPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. ScinoPharm Peptide Synthesis CDMO Services Product Portfolio Table 79. ScinoPharm Recent Development Table 80. JPT Company Information Table 81. JPT Business Overview Table 82. JPT Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. JPT Peptide Synthesis CDMO Services Product Portfolio Table 84. JPT Recent Development Table 85. CBL Company Information Table 86. CBL Business Overview Table 87. CBL Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. CBL Peptide Synthesis CDMO Services Product Portfolio Table 89. CBL Recent Development Table 90. Piramal Pharma Company Information Table 91. Piramal Pharma Business Overview Table 92. Piramal Pharma Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio Table 94. Piramal Pharma Recent Development Table 95. CPC Scientific Company Information Table 96. CPC Scientific Business Overview Table 97. CPC Scientific Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. CPC Scientific Peptide Synthesis CDMO Services Product Portfolio Table 99. CPC Scientific Recent Development Table 100. Creative Peptides Company Information Table 101. Creative Peptides Business Overview Table 102. Creative Peptides Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Creative Peptides Peptide Synthesis CDMO Services Product Portfolio Table 104. Creative Peptides Recent Development Table 105. Chinese Peptide Company Company Information Table 106. Chinese Peptide Company Business Overview Table 107. Chinese Peptide Company Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio Table 109. Chinese Peptide Company Recent Development Table 110. ChengDu ShengNuo Biotec Company Information Table 111. ChengDu ShengNuo Biotec Business Overview Table 112. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio Table 114. ChengDu ShengNuo Biotec Recent Development Table 115. AppTec Co., Ltd. Company Information Table 116. AppTec Co., Ltd. Business Overview Table 117. AppTec Co., Ltd. Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio Table 119. AppTec Co., Ltd. Recent Development Table 120. GL Biochem Company Information Table 121. GL Biochem Business Overview Table 122. GL Biochem Peptide Synthesis CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. GL Biochem Peptide Synthesis CDMO Services Product Portfolio Table 124. GL Biochem Recent Development Table 125. North America Peptide Synthesis CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Peptide Synthesis CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Peptide Synthesis CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Peptide Synthesis CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Peptide Synthesis CDMO Services Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Peptide Synthesis CDMO Services Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe Peptide Synthesis CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Peptide Synthesis CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Peptide Synthesis CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Peptide Synthesis CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Peptide Synthesis CDMO Services Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe Peptide Synthesis CDMO Services Revenue by Country (US$ Million) & (2027-2032) Table 139. China Peptide Synthesis CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 140. China Peptide Synthesis CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 141. China Peptide Synthesis CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 142. China Peptide Synthesis CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Peptide Synthesis CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Peptide Synthesis CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Peptide Synthesis CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Peptide Synthesis CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Peptide Synthesis CDMO Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Peptide Synthesis CDMO Services Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia Peptide Synthesis CDMO Services Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA Peptide Synthesis CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA Peptide Synthesis CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA Peptide Synthesis CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Peptide Synthesis CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA Peptide Synthesis CDMO Services Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA Peptide Synthesis CDMO Services Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Peptide Synthesis CDMO Services Image Figure 2. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptide Synthesis CDMO Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. GMP Services Image Figure 5. Non-GMP Services Image Figure 6. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Peptide Synthesis CDMO Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Commercial Image Figure 9. Scientific Research Image Figure 10. Other Image Figure 11. Global Peptide Synthesis CDMO Services Market Size (US$ Million) & (2021-2032) Figure 12. Global Peptide Synthesis CDMO Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Peptide Synthesis CDMO Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Peptide Synthesis CDMO Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Peptide Synthesis CDMO Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Peptide Synthesis CDMO Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2021-2032) Figure 19. Global Peptide Synthesis CDMO Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021-2032) Figure 22. North America Peptide Synthesis CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032) Figure 24. North America Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032) Figure 25. North America Peptide Synthesis CDMO Services Revenue Share by Country (2021-2032) Figure 26. United States Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Peptide Synthesis CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032) Figure 31. Europe Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032) Figure 32. Europe Peptide Synthesis CDMO Services Revenue Share by Country (2021-2032) Figure 33. Germany Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Peptide Synthesis CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032) Figure 43. China Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032) Figure 44. Asia Peptide Synthesis CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032) Figure 46. Asia Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032) Figure 47. Asia Peptide Synthesis CDMO Services Revenue Share by Region (2021-2032) Figure 48. Japan Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Peptide Synthesis CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032) Figure 56. SAMEA Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032) Figure 57. SAMEA Peptide Synthesis CDMO Services Revenue Share by Country (2021-2032) Figure 58. Brazil Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Peptide Synthesis CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • GMP Services
  • Non-GMP Services
Applications
  • Commercial
  • Scientific Research
  • Other
Companies covered
  • Bachem
  • CordenPharma
  • PolyPeptide
  • AmbioPharm
  • Genscript
  • Thermo Fisher
  • USV Peptides
  • Bio Basic
  • ScinoPharm
  • JPT
  • CBL
  • Piramal Pharma
  • CPC Scientific
  • Creative Peptides
  • Chinese Peptide Company
  • ChengDu ShengNuo Biotec
  • AppTec Co., Ltd.
  • GL Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Peptide Synthesis CDMO Services Market by Type
  3. 1.2.1 Global Peptide Synthesis CDMO Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 GMP Services
  5. 1.2.3 Non-GMP Services
  6. 1.3 Peptide Synthesis CDMO Services Market by Application
  7. 1.3.1 Global Peptide Synthesis CDMO Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Commercial
  9. 1.3.3 Scientific Research
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Peptide Synthesis CDMO Services Market Dynamics
  1. 2.1 Peptide Synthesis CDMO Services Industry Trends
  2. 2.2 Peptide Synthesis CDMO Services Industry Drivers
  3. 2.3 Peptide Synthesis CDMO Services Industry Opportunities and Challenges
  4. 2.4 Peptide Synthesis CDMO Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Peptide Synthesis CDMO Services Market Perspective (2021-2032)
  2. 3.2 Global Peptide Synthesis CDMO Services Growth Trends by Region
  3. 3.2.1 Global Peptide Synthesis CDMO Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Peptide Synthesis CDMO Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Peptide Synthesis CDMO Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Peptide Synthesis CDMO Services Revenue by Players
  2. 4.1.1 Global Peptide Synthesis CDMO Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Peptide Synthesis CDMO Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Peptide Synthesis CDMO Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Peptide Synthesis CDMO Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Peptide Synthesis CDMO Services Key Players Headquarters & Area Served
  7. 4.4 Global Peptide Synthesis CDMO Services Players, Product Type & Application
  8. 4.5 Global Peptide Synthesis CDMO Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Peptide Synthesis CDMO Services Market CR5 and HHI
  11. 4.6.3 2025 Peptide Synthesis CDMO Services Tier 1, Tier 2, and Tier 3
5 Peptide Synthesis CDMO Services Market Size by Type
  1. 5.1 Global Peptide Synthesis CDMO Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide Synthesis CDMO Services Revenue by Type (2021-2032)
  3. 5.3 Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2021-2032)
6 Peptide Synthesis CDMO Services Market Size by Application
  1. 6.1 Global Peptide Synthesis CDMO Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Peptide Synthesis CDMO Services Revenue by Application (2021-2032)
  3. 6.3 Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bachem
  2. 7.1.1 Bachem Company Information
  3. 7.1.2 Bachem Business Overview
  4. 7.1.3 Bachem Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bachem Peptide Synthesis CDMO Services Product Portfolio
  6. 7.1.5 Bachem Recent Developments
  7. 7.2 CordenPharma
  8. 7.2.1 CordenPharma Company Information
  9. 7.2.2 CordenPharma Business Overview
  10. 7.2.3 CordenPharma Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CordenPharma Peptide Synthesis CDMO Services Product Portfolio
  12. 7.2.5 CordenPharma Recent Developments
  13. 7.3 PolyPeptide
  14. 7.3.1 PolyPeptide Company Information
  15. 7.3.2 PolyPeptide Business Overview
  16. 7.3.3 PolyPeptide Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 PolyPeptide Peptide Synthesis CDMO Services Product Portfolio
  18. 7.3.5 PolyPeptide Recent Developments
  19. 7.4 AmbioPharm
  20. 7.4.1 AmbioPharm Company Information
  21. 7.4.2 AmbioPharm Business Overview
  22. 7.4.3 AmbioPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AmbioPharm Peptide Synthesis CDMO Services Product Portfolio
  24. 7.4.5 AmbioPharm Recent Developments
  25. 7.5 Genscript
  26. 7.5.1 Genscript Company Information
  27. 7.5.2 Genscript Business Overview
  28. 7.5.3 Genscript Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Genscript Peptide Synthesis CDMO Services Product Portfolio
  30. 7.5.5 Genscript Recent Developments
  31. 7.6 Thermo Fisher
  32. 7.6.1 Thermo Fisher Company Information
  33. 7.6.2 Thermo Fisher Business Overview
  34. 7.6.3 Thermo Fisher Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio
  36. 7.6.5 Thermo Fisher Recent Developments
  37. 7.7 USV Peptides
  38. 7.7.1 USV Peptides Company Information
  39. 7.7.2 USV Peptides Business Overview
  40. 7.7.3 USV Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 USV Peptides Peptide Synthesis CDMO Services Product Portfolio
  42. 7.7.5 USV Peptides Recent Developments
  43. 7.8 Bio Basic
  44. 7.8.1 Bio Basic Company Information
  45. 7.8.2 Bio Basic Business Overview
  46. 7.8.3 Bio Basic Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bio Basic Peptide Synthesis CDMO Services Product Portfolio
  48. 7.8.5 Bio Basic Recent Developments
  49. 7.9 ScinoPharm
  50. 7.9.1 ScinoPharm Company Information
  51. 7.9.2 ScinoPharm Business Overview
  52. 7.9.3 ScinoPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 ScinoPharm Peptide Synthesis CDMO Services Product Portfolio
  54. 7.9.5 ScinoPharm Recent Developments
  55. 7.10 JPT
  56. 7.10.1 JPT Company Information
  57. 7.10.2 JPT Business Overview
  58. 7.10.3 JPT Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JPT Peptide Synthesis CDMO Services Product Portfolio
  60. 7.10.5 JPT Recent Developments
  61. 7.11 CBL
  62. 7.11.1 CBL Company Information
  63. 7.11.2 CBL Business Overview
  64. 7.11.3 CBL Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CBL Peptide Synthesis CDMO Services Product Portfolio
  66. 7.11.5 CBL Recent Developments
  67. 7.12 Piramal Pharma
  68. 7.12.1 Piramal Pharma Company Information
  69. 7.12.2 Piramal Pharma Business Overview
  70. 7.12.3 Piramal Pharma Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio
  72. 7.12.5 Piramal Pharma Recent Developments
  73. 7.13 CPC Scientific
  74. 7.13.1 CPC Scientific Company Information
  75. 7.13.2 CPC Scientific Business Overview
  76. 7.13.3 CPC Scientific Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CPC Scientific Peptide Synthesis CDMO Services Product Portfolio
  78. 7.13.5 CPC Scientific Recent Developments
  79. 7.14 Creative Peptides
  80. 7.14.1 Creative Peptides Company Information
  81. 7.14.2 Creative Peptides Business Overview
  82. 7.14.3 Creative Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Creative Peptides Peptide Synthesis CDMO Services Product Portfolio
  84. 7.14.5 Creative Peptides Recent Developments
  85. 7.15 Chinese Peptide Company
  86. 7.15.1 Chinese Peptide Company Company Information
  87. 7.15.2 Chinese Peptide Company Business Overview
  88. 7.15.3 Chinese Peptide Company Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio
  90. 7.15.5 Chinese Peptide Company Recent Developments
  91. 7.16 ChengDu ShengNuo Biotec
  92. 7.16.1 ChengDu ShengNuo Biotec Company Information
  93. 7.16.2 ChengDu ShengNuo Biotec Business Overview
  94. 7.16.3 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio
  96. 7.16.5 ChengDu ShengNuo Biotec Recent Developments
  97. 7.17 AppTec Co., Ltd.
  98. 7.17.1 AppTec Co., Ltd. Company Information
  99. 7.17.2 AppTec Co., Ltd. Business Overview
  100. 7.17.3 AppTec Co., Ltd. Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio
  102. 7.17.5 AppTec Co., Ltd. Recent Developments
  103. 7.18 GL Biochem
  104. 7.18.1 GL Biochem Company Information
  105. 7.18.2 GL Biochem Business Overview
  106. 7.18.3 GL Biochem Peptide Synthesis CDMO Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 GL Biochem Peptide Synthesis CDMO Services Product Portfolio
  108. 7.18.5 GL Biochem Recent Developments
8 North America
  1. 8.1 North America Peptide Synthesis CDMO Services Revenue (2021-2032)
  2. 8.2 North America Peptide Synthesis CDMO Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Peptide Synthesis CDMO Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Peptide Synthesis CDMO Services Revenue by Type (2027-2032)
  5. 8.3 North America Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Peptide Synthesis CDMO Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Peptide Synthesis CDMO Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Peptide Synthesis CDMO Services Revenue by Application (2027-2032)
  9. 8.5 North America Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Peptide Synthesis CDMO Services Revenue by Country
  11. 8.6.1 North America Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Peptide Synthesis CDMO Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Peptide Synthesis CDMO Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Peptide Synthesis CDMO Services Revenue (2021-2032)
  2. 9.2 Europe Peptide Synthesis CDMO Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Peptide Synthesis CDMO Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Peptide Synthesis CDMO Services Revenue by Type (2027-2032)
  5. 9.3 Europe Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Peptide Synthesis CDMO Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Peptide Synthesis CDMO Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Peptide Synthesis CDMO Services Revenue by Application (2027-2032)
  9. 9.5 Europe Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Peptide Synthesis CDMO Services Revenue by Country
  11. 9.6.1 Europe Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Peptide Synthesis CDMO Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Peptide Synthesis CDMO Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Peptide Synthesis CDMO Services Revenue (2021-2032)
  2. 10.2 China Peptide Synthesis CDMO Services Revenue by Type (2021-2032)
  3. 10.2.1 China Peptide Synthesis CDMO Services Revenue by Type (2021-2026)
  4. 10.2.2 China Peptide Synthesis CDMO Services Revenue by Type (2027-2032)
  5. 10.3 China Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032)
  6. 10.4 China Peptide Synthesis CDMO Services Revenue by Application (2021-2032)
  7. 10.4.1 China Peptide Synthesis CDMO Services Revenue by Application (2021-2026)
  8. 10.4.2 China Peptide Synthesis CDMO Services Revenue by Application (2027-2032)
  9. 10.5 China Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Peptide Synthesis CDMO Services Revenue (2021-2032)
  2. 11.2 Asia Peptide Synthesis CDMO Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Peptide Synthesis CDMO Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Peptide Synthesis CDMO Services Revenue by Type (2027-2032)
  5. 11.3 Asia Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Peptide Synthesis CDMO Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Peptide Synthesis CDMO Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Peptide Synthesis CDMO Services Revenue by Application (2027-2032)
  9. 11.5 Asia Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Peptide Synthesis CDMO Services Revenue by Country
  11. 11.6.1 Asia Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Peptide Synthesis CDMO Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Peptide Synthesis CDMO Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Peptide Synthesis CDMO Services Revenue (2021-2032)
  2. 12.2 SAMEA Peptide Synthesis CDMO Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Peptide Synthesis CDMO Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Peptide Synthesis CDMO Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Peptide Synthesis CDMO Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Peptide Synthesis CDMO Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Peptide Synthesis CDMO Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Peptide Synthesis CDMO Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Peptide Synthesis CDMO Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Peptide Synthesis CDMO Services Revenue by Country
  11. 12.6.1 SAMEA Peptide Synthesis CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Peptide Synthesis CDMO Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Peptide Synthesis CDMO Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst